Your browser doesn't support javascript.
loading
Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang, Y J; Sun, Z L; Wu, W G; Xing, J; He, Y F; Xin, D M; Han, P.
Afiliação
  • Tang YJ; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China.
  • Sun ZL; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China.
  • Wu WG; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China.
  • Xing J; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China.
  • He YF; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China.
  • Xin DM; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China.
  • Han P; Department of Gynecology and Obstetrics, Hebei United University Affiliated Hospital, Tangshan, Hebei Province, China hanping800@126.com.
Genet Mol Res ; 14(1): 2450-60, 2015 Mar 30.
Article em En | MEDLINE | ID: mdl-25867391

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piridinas / Cisplatino / Tirfostinas / Fator de Transcrição STAT3 / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Genet Mol Res Assunto da revista: BIOLOGIA MOLECULAR / GENETICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piridinas / Cisplatino / Tirfostinas / Fator de Transcrição STAT3 / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Genet Mol Res Assunto da revista: BIOLOGIA MOLECULAR / GENETICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China